Association between adverse clinical outcome in human disease caused by novel influenza A H7N9 virus and sustained viral shedding and emergence of antiviral resistance.
about
Corticosteroids as adjunctive therapy in the treatment of influenzaAvian Influenza Viruses, Inflammation, and CD8(+) T Cell ImmunityClinical Implications of Antiviral Resistance in InfluenzaInfluenza treatment and prophylaxis with neuraminidase inhibitors: a reviewExperimental primates and non-human primate (NHP) models of human diseases in China: current status and progressUsing the Ferret as an Animal Model for Investigating Influenza Antiviral EffectivenessInfluenza virus hemagglutinin stalk-based antibodies and vaccinesHuman H7N9 avian influenza virus infection: a review and pandemic risk assessmentSafety and efficacy of peramivir for influenza treatmentThe Therapeutic Effect of Pamidronate on Lethal Avian Influenza A H7N9 Virus Infected Humanized MiceCrystallographic Fragment Screening and Structure-Based Optimization Yields a New Class of Influenza Endonuclease InhibitorsCharacterization of two distinct neuraminidases from avian-origin human-infecting H7N9 influenza virusesPrevention of influenza by targeting host receptors using engineered proteinsRisk of resistant avian influenza A virus in wild waterfowl as a result of environmental release of oseltamivirRandomized, double-blind, placebo-controlled clinical trial to assess the safety and effectiveness of a novel dual-action oral topical formulation against upper respiratory infectionsInhibition of influenza H7 hemagglutinin-mediated entryIn vitro anti-influenza virus activities of a new lignan glycoside from the latex of Calotropis giganteaIn vitro exposure system for study of aerosolized influenza virusInvesting in Immunity: Prepandemic Immunization to Combat Future Influenza Pandemics.Unique Determinants of Neuraminidase Inhibitor Resistance among N3, N7, and N9 Avian Influenza Viruses.Influenza A(H7N9) virus acquires resistance-related neuraminidase I222T substitution when infected mallards are exposed to low levels of oseltamivir in water.Oseltamivir-resistant influenza A (H1N1) virus strain with an H274Y mutation in neuraminidase persists without drug pressure in infected mallardsJapanese Surveillance Systems and Treatment for Influenza.The pharmacological management of severe influenza infection - 'existing and emerging therapies'.Avian influenza virus in pregnancy.One-shot vaccination with an insect cell-derived low-dose influenza A H7 virus-like particle preparation protects mice against H7N9 challenge.H3 stalk-based chimeric hemagglutinin influenza virus constructs protect mice from H7N9 challengeEmergence of a novel drug resistant H7N9 influenza virus: evidence based clinical potential of a natural IFN-α for infection control and treatment.Assessment of influenza virus hemagglutinin stalk-based immunity in ferrets.Divergent H7 immunogens offer protection from H7N9 virus challenge.Comparison of patients hospitalized with influenza A subtypes H7N9, H5N1, and 2009 pandemic H1N1.Transcriptomic characterization of the novel avian-origin influenza A (H7N9) virus: specific host response and responses intermediate between avian (H5N1 and H7N7) and human (H3N2) viruses and implications for treatment optionsPreliminary success in the characterization and management of a sudden breakout of a novel H7N9 influenza A virus.Identifying areas with a high risk of human infection with the avian influenza A (H7N9) virus in East AsiaConsiderations for the rapid deployment of vaccines against H7N9 influenza.Influenza virus A/Anhui/1/2013 (H7N9) replicates efficiently in the upper and lower respiratory tracts of cynomolgus macaques.Entry properties and entry inhibitors of a human H7N9 influenza virus.Pandemic potential of avian influenza A (H7N9) viruses.Overview of the 3rd isirv-Antiviral Group Conference--advances in clinical managementPreexisting human antibodies neutralize recently emerged H7N9 influenza strains.
P2860
Q24186045-CC894778-A0A8-4FF0-93CC-1EFD85DCB47FQ26765927-B3C0CB5B-892A-4B51-80B0-398299AB45A0Q26782746-07A26CCA-C977-452A-B254-CCD238E46429Q26860032-368877B5-9640-41D9-BE49-0EEC4DB6362CQ26860345-4B5E6325-40CB-4FC2-B0B4-596527271188Q27000668-220D14EB-F200-4BFB-A471-8C648455019AQ27001190-A5F428AE-BEC3-46DC-9B1B-8EA4151CEF98Q27025880-FD805942-087F-40D6-8BA8-8854F9817F8AQ27027408-3862DADE-346E-4E46-AF12-F5EE05C1B5EBQ27322928-8DED391A-9F35-43E2-8B0E-F88BFC1C9422Q27679805-452FFD31-874C-42F8-B7F2-73A13733739FQ27680477-DA548F75-1AA1-4B30-AF9D-A9EF954DAFE8Q27683378-958D7E67-D064-477A-9DA8-424662F301C6Q28066861-86177043-CC1E-4373-85A5-895DF3D28305Q28468567-AACBFE7F-73C6-42D4-8417-23A1AF98F952Q28534616-81064770-2609-4A33-8A67-A94C53262CE7Q28541723-3BBFE4FB-4C31-4344-B89A-205B15D5A958Q29048607-A79FEF3C-7315-47EB-82B7-5511D2D18D16Q30202032-81D3E4B2-870A-4D2B-8451-E4B17AA0412DQ30202859-DFB0CAE8-6AA8-477D-A22D-C8D133206AA2Q30203367-76D084E3-9C8A-4818-A89C-DC80DE66F23BQ30205021-6163CF30-16E7-4DA3-8C4A-5CB0A2C92727Q30239895-62C289A5-D059-4E29-BF82-39D333B53CD8Q30243907-373A4441-3541-453C-9071-E062787557FFQ30250287-F1FAEE2D-0C67-478D-8B13-36601D9E849BQ30355863-52AAB5EE-93FE-4885-B655-FD6D454FDC8CQ30356429-B207AEBE-2E08-4424-82F4-702702EAE6B7Q30357014-4DE77C8F-3B74-4FE3-9A2E-B3DDE1627241Q30357665-40B28C56-32E7-4807-9D63-EB99670A59A0Q30358196-3605ACBD-1B7E-47CE-8973-16D507314418Q30358617-4471EAEF-06DD-43BC-B523-5AA3D4173540Q30358704-EEF1D888-52ED-491F-A726-819620F0E2E2Q30358886-49782E9D-900F-4D97-93B9-3C23B17D6005Q30360330-947BBE94-48A8-466C-8B5E-268EADE1A574Q30364635-DDD7F694-A437-466B-8E14-E982534E858CQ30365646-2143D4DB-4BD0-403E-935B-53FB7B191E9CQ30366812-CBDDDC2F-C9ED-49B8-9D86-6F96914DD5E3Q30367254-18AE36C6-147F-46D4-87A0-0287904156B3Q30368680-114D2430-E49E-47A1-B3A2-7082DC304301Q30371836-882C5EA8-A0A2-4FAB-8A0A-191A3D86FB65
P2860
Association between adverse clinical outcome in human disease caused by novel influenza A H7N9 virus and sustained viral shedding and emergence of antiviral resistance.
description
2013 nî lūn-bûn
@nan
2013 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Association between adverse cl ...... gence of antiviral resistance.
@ast
Association between adverse cl ...... gence of antiviral resistance.
@en
type
label
Association between adverse cl ...... gence of antiviral resistance.
@ast
Association between adverse cl ...... gence of antiviral resistance.
@en
prefLabel
Association between adverse cl ...... gence of antiviral resistance.
@ast
Association between adverse cl ...... gence of antiviral resistance.
@en
P2093
P1433
P1476
Association between adverse cl ...... gence of antiviral resistance.
@en
P2093
Bisheng Shi
Hui-Ling Yen
Huijie Chen
Jianhua Li
P304
P356
10.1016/S0140-6736(13)61125-3
P407
P50
P577
2013-05-29T00:00:00Z